Aveanna Healthcare (NASDAQ:AVAH) Trading Down 10% – Time to Sell?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) traded down 10% during trading on Thursday . The company traded as low as $5.93 and last traded at $6.2180. 401,297 shares traded hands during trading, a decline of 65% from the average session volume of 1,157,270 shares. The stock had previously closed at $6.91.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results beat consensus — revenue grew strongly year‑over‑year and the company topped EPS and revenue estimates, providing fundamental support for the stock. Press Release
• Positive Sentiment: Raymond James upgraded AVAH to “strong-buy” and set a $13 price target, which is a bullish catalyst and likely helping intraday buying interest. Finviz item
• Neutral Sentiment: BMO trimmed its price target from $11 to $10 but maintained an “outperform” rating — a modest pullback in upside but not a negative rating change. Benzinga
• Neutral Sentiment: Aveanna issued 2026 guidance and a growth outlook; the details are being parsed by investors and helped explain the mixed market reaction (earnings beat vs. cautious forward commentary). TipRanks
• Neutral Sentiment: Reported short‑interest entries show anomalous “0 shares”/NaN data for March (data likely erroneous), so short‑interest signals are not meaningful right now.
• Negative Sentiment: Truist lowered its price target to $9 and moved to a “hold” rating, reducing analyst support and putting downside pressure on the stock. Benzinga
• Negative Sentiment: Market headlines flagged that Aveanna’s revenue outlook/trend in guidance trailed some consensus expectations, which prompted a pullback in some coverage and weighed on sentiment. MSN

Analysts Set New Price Targets

A number of equities analysts have issued reports on AVAH shares. UBS Group increased their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, January 15th. Truist Financial cut their price objective on Aveanna Healthcare from $10.00 to $9.00 and set a “hold” rating for the company in a report on Friday. William Blair started coverage on Aveanna Healthcare in a research note on Monday, December 8th. They set an “outperform” rating for the company. BMO Capital Markets lowered their target price on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $10.81.

Aveanna Healthcare Stock Performance

The stock has a market cap of $1.36 billion, a price-to-earnings ratio of 6.39 and a beta of 2.07. The company’s 50-day simple moving average is $7.84 and its 200-day simple moving average is $8.49. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Insider Buying and Selling at Aveanna Healthcare

In other news, CFO Matthew Buckhalter sold 13,512 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the sale, the chief financial officer directly owned 529,243 shares of the company’s stock, valued at $3,815,842.03. This represents a 2.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Patrick A. Cunningham sold 18,436 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $132,923.56. Following the completion of the transaction, the insider owned 337,755 shares of the company’s stock, valued at $2,435,213.55. This trade represents a 5.18% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 998,595 shares of company stock worth $7,567,770. 7.80% of the stock is owned by insiders.

Institutional Trading of Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Teacher Retirement System of Texas lifted its stake in Aveanna Healthcare by 232.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 224,375 shares of the company’s stock worth $1,990,000 after acquiring an additional 156,947 shares in the last quarter. AustralianSuper Pty Ltd purchased a new position in Aveanna Healthcare during the 3rd quarter valued at about $15,743,000. Assenagon Asset Management S.A. acquired a new position in shares of Aveanna Healthcare in the 3rd quarter valued at about $7,356,000. Squarepoint Ops LLC increased its holdings in shares of Aveanna Healthcare by 207.0% in the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock valued at $2,510,000 after purchasing an additional 323,656 shares during the period. Finally, Algert Global LLC lifted its position in shares of Aveanna Healthcare by 120.1% in the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after purchasing an additional 557,898 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.